Traditionally, insulin from pig pancreas was used, it matches human insulin closely
More recently, human insulin produced by genetically modified Escherichia coli bacteria
Genetically engineered bacteria; DNA altered + human insulin gene inserted
Advantages
Exact copy of human insulin; faster acting + more effective
Less chance of developing insulin tolerance
Less chance of rejection due to immune response
Lower infection risk
Cheaper to manufacture insulin than extract it from animals
Manufacturing process is more adaptable to demand
Less moral objections of insulin produced by bacteria than that extracted from animals
Stem cells
Possible to treat Type 1
Inject into pancreas
Scientists found precursor cells in adult mice pancreas
If similar cells in human pancreas, could be used to make new beta cells
Give patient freedom from daily injections